SG Americas Securities’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Buy |
+10,348
| New | +$447K | ﹤0.01% | 1585 |
|
|
2024
Q4 | – | Sell |
-37,151
| Closed | -$946K | – | 2707 |
|
|
2024
Q3 | $946K | Sell |
37,151
-16,714
| -31% | -$426K | ﹤0.01% | 977 |
|
|
2024
Q2 | $1.36M | Buy |
53,865
+47,578
| +757% | +$1.2M | 0.01% | 1059 |
|
|
2024
Q1 | $194K | Buy |
6,287
+2,545
| +68% | +$78.5K | ﹤0.01% | 1773 |
|
|
2023
Q4 | $151K | Sell |
3,742
-914
| -20% | -$36.9K | ﹤0.01% | 2198 |
|
|
2023
Q3 | $123K | Buy |
+4,656
| New | +$123K | ﹤0.01% | 2403 |
|
|
2023
Q2 | – | Sell |
-19,545
| Closed | -$324K | – | 2000 |
|
|
2023
Q1 | $324K | Buy |
+19,545
| New | +$324K | ﹤0.01% | 1887 |
|
|
2022
Q4 | – | Sell |
-21,316
| Closed | -$212K | – | 2711 |
|
|
2022
Q3 | $212K | Sell |
21,316
-100,995
| -83% | -$1M | ﹤0.01% | 2025 |
|
|
2022
Q2 | $1.11M | Buy |
122,311
+92,177
| +306% | +$837K | 0.01% | 1079 |
|
|
2022
Q1 | $306K | Buy |
30,134
+15,939
| +112% | +$162K | ﹤0.01% | 1958 |
|
|
2021
Q4 | $237K | Sell |
14,195
-11,142
| -44% | -$186K | ﹤0.01% | 2333 |
|
|
2021
Q3 | $1.19M | Buy |
25,337
+6,657
| +36% | +$312K | 0.01% | 1603 |
|
|
2021
Q2 | $1.14M | Buy |
18,680
+4,185
| +29% | +$255K | 0.01% | 1343 |
|
|
2021
Q1 | $893K | Sell |
14,495
-4,037
| -22% | -$249K | ﹤0.01% | 1480 |
|
|
2020
Q4 | $1.32M | Buy |
18,532
+3,374
| +22% | +$240K | 0.01% | 1199 |
|
|
2020
Q3 | $569K | Sell |
15,158
-5,040
| -25% | -$189K | ﹤0.01% | 1286 |
|
|
2020
Q2 | $659K | Buy |
20,198
+5,406
| +37% | +$176K | 0.01% | 1545 |
|
|
2020
Q1 | $429K | Buy |
14,792
+9,314
| +170% | +$270K | ﹤0.01% | 1618 |
|
|
2019
Q4 | $192K | Buy |
+5,478
| New | +$192K | ﹤0.01% | 2152 |
|
|
2019
Q3 | – | Sell |
-17,647
| Closed | -$476K | – | 2460 |
|
|
2019
Q2 | $476K | Buy |
+17,647
| New | +$476K | ﹤0.01% | 1672 |
|